RecruitingACTRN12624000178549

Electro-Magnetic-Frequency Therapy (EMF) for Chronic Fatigue

Effect of Electro-Magnetic-Frequency Therapy (EMF) on Circulating Rare Cell (CRC) count in chronic fatigue patients

Sponsor

AProf Dr Karin Ried

Enrollment

100 participants

Start Date

Mar 1, 2024

Study Type

Interventional

Conditions

Viral Reactivation with Cyto-Megalo-Virus (CMV)Viral Reactivation with Herpes Simplex Virus (HSV)Viral Reactivation with Epstein-Barr Virus (EBV)Chronic fatigue

Summary

The prevalence of chronic fatigue is high in Australia. There is a need for better understanding of underlying disease patho-physiology and reliable assessments of treatment effectiveness. This intervention study aims to assess the treatment effect of Electromagnetic Frequency (EMF) therapy for patients with chronic fatigue using the viral reactivation test, a combination of the cytology-based Circulating Rare Cell (CRC) blood test, and viral marker testing for dormant viruses such as Epstein Barr Virus (EBV), Cyto-megalo-virus (CMV), or Herpes Simplex Virus (HSV). Who is it for? You may be eligible for this study, if you have chronic fatigue. Study details Patients will undergo an intial EMF session of 60-90 min to assess treatment effectiveness of the chosen patient-specific frequency program. Effectiveness will be assessed by blood tests measuring the number of viral reactivated Circulating Rare Cells (CRC) before and 1 day after treatment. If successful, the patient will discuss with their health practitioner a 12 week treatment plan, which may involved twice weekly EMF sessions for 12 weeks. A follow-up CTC test at 3 and 6 months is scheduled to assess treatment effectiveness in the context of long-term clinical outcome. It is hoped, that this study will provide insight into the effectiveness of EMF therapy for viral reactivated chronic fatigue, with the aim to reduce viral reactivation and improve symptoms and quality of life.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

Chronic fatigue — particularly when linked to the reactivation of dormant viruses such as Epstein-Barr virus (the cause of glandular fever), cytomegalovirus, or herpes simplex virus — can be profoundly debilitating. Despite how common it is, treatment options remain limited and poorly understood. This study investigates whether electromagnetic frequency (EMF) therapy can reduce viral reactivation and improve symptoms. Participants start with a 60 to 90-minute EMF session, and blood tests measure viral reactivation levels before and one day after. If the results are promising, a 12-week treatment plan with twice-weekly sessions follows, with further blood tests at 3 and 6 months to assess whether the improvement is sustained. You may be eligible if you are 18 or older and have chronic fatigue associated with viral reactivation. People with electronic implants such as pacemakers, cochlear implants, or defibrillators, or those unable to commit to regular treatment sessions over 3 months, are not eligible.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Print for Your Doctor Check Your Eligibility

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Electro-Magnetic-Frequency Therapy (EMF) consists of a suite of low frequency waves (<25x10^6 Hz) – lower than those emitted by mobile phones (1x10^8 Hz) – specific to the underlying infections / pathogens. We will use the EMF device Spooky2 plus Phanotron plasma bulb or plasma tube, and a suite of frequencies specific to the patient's illness as per EMF/Rife catalogue ranging between 1 Hz and 3.5 MHz. EMF therapy is adminstered by a EMF trained nurse, who will also monitor adherence to the therapy. EMF waves are transmitted through the air whilst the patient is sitting closely (~10 cm-100cm) to the frequency emitting plasma tube. EMF sessions are typically of 60-90 min length, during which the patient can undertake some stationary relaxing activities, e.g. reading, writing, meditating, without using an electronic device. A one-off EMF therapy session is scheduled initally, and treatment effectiveness assessed by 2x blood tests before and after the session. The patient will then discuss with their health practitioner a treatment program of 12 week duration, e.g. twice weekly sessions for 12 weeks.

Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12624000178549